1. Home
  2. SFM vs PRAX Comparison

SFM vs PRAX Comparison

Compare SFM & PRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sprouts Farmers Market Inc.

SFM

Sprouts Farmers Market Inc.

HOLD

Current Price

$75.87

Market Cap

6.9B

ML Signal

HOLD

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

HOLD

Current Price

$320.98

Market Cap

9.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SFM
PRAX
Founded
2002
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Food Chains
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.9B
9.6B
IPO Year
2013
2020

Fundamental Metrics

Financial Performance
Metric
SFM
PRAX
Price
$75.87
$320.98
Analyst Decision
Buy
Strong Buy
Analyst Count
12
15
Target Price
$112.92
$572.13
AVG Volume (30 Days)
2.9M
364.5K
Earning Date
05-25-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
41.60
N/A
EPS
5.31
N/A
Revenue
$8,806,159,000.00
N/A
Revenue This Year
$9.03
N/A
Revenue Next Year
$7.40
$6,395.88
P/E Ratio
$14.66
N/A
Revenue Growth
14.08
N/A
52 Week Low
$64.75
$26.70
52 Week High
$182.00
$354.87

Technical Indicators

Market Signals
Indicator
SFM
PRAX
Relative Strength Index (RSI) 57.89 51.83
Support Level $64.88 $290.36
Resistance Level $82.28 N/A
Average True Range (ATR) 3.48 17.96
MACD 1.22 -2.78
Stochastic Oscillator 77.62 51.76

Price Performance

Historical Comparison
SFM
PRAX

About SFM Sprouts Farmers Market Inc.

Sprouts Farmers Market Inc offers a specialty grocery experience featuring an open layout with fresh produce at the heart of the store. Sprouts inspire wellness naturally with a carefully curated assortment products paired with purpose-driven people. The company continues to bring products made with lifestyle-friendly ingredients such as organic, plant-based, and gluten-free. It approximately has 407 stores in nearly 23 states. The Company has one operating segment that is healthy grocery stores.

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

Share on Social Networks: